Difficulty: Medium
Average Score: 88%
Practice
Indication for cholecalciferol administration is:
Correct answer
D
Rationale
In pharmacology, understanding the indications for drug administration is crucial for safe and effective patient care. In the case of cholecalciferol (vitamin D), the correct indication for its administration is option D) Malabsorption of vitamin D from intestine.
Cholecalciferol is a form of vitamin D that is commonly used to treat vitamin D deficiency. When there is malabsorption of vitamin D from the intestine, either due to gastrointestinal disorders or other medical conditions affecting absorption, supplementing with cholecalciferol is necessary to ensure adequate levels of this essential vitamin in the body.
Now, let's discuss why the other options are incorrect:
A) Hypercalcemia: Administering cholecalciferol in a patient with hypercalcemia can exacerbate the condition as vitamin D promotes calcium absorption. It is contraindicated in hypercalcemia.
B) Parathyroid hormone deficiency: Cholecalciferol is not indicated for parathyroid hormone deficiency. Treatment for this condition involves addressing the underlying cause and possibly hormone replacement therapy.
C) Primary hyperparathyroidism: In primary hyperparathyroidism, there is excessive production of parathyroid hormone, leading to increased calcium levels. Administering cholecalciferol can worsen the hypercalcemia associated with this condition.
Educationally, this question highlights the importance of understanding the rationale behind drug indications to provide safe and effective pharmacological care. Healthcare providers must be able to differentiate between various conditions and their appropriate treatments to optimize patient outcomes and prevent adverse effects.
Cholecalciferol is a form of vitamin D that is commonly used to treat vitamin D deficiency. When there is malabsorption of vitamin D from the intestine, either due to gastrointestinal disorders or other medical conditions affecting absorption, supplementing with cholecalciferol is necessary to ensure adequate levels of this essential vitamin in the body.
Now, let's discuss why the other options are incorrect:
A) Hypercalcemia: Administering cholecalciferol in a patient with hypercalcemia can exacerbate the condition as vitamin D promotes calcium absorption. It is contraindicated in hypercalcemia.
B) Parathyroid hormone deficiency: Cholecalciferol is not indicated for parathyroid hormone deficiency. Treatment for this condition involves addressing the underlying cause and possibly hormone replacement therapy.
C) Primary hyperparathyroidism: In primary hyperparathyroidism, there is excessive production of parathyroid hormone, leading to increased calcium levels. Administering cholecalciferol can worsen the hypercalcemia associated with this condition.
Educationally, this question highlights the importance of understanding the rationale behind drug indications to provide safe and effective pharmacological care. Healthcare providers must be able to differentiate between various conditions and their appropriate treatments to optimize patient outcomes and prevent adverse effects.